Department of Pediatric Genetics, S.B.Ü. Dr. Behçet Uz Children's Education and Research Hospital, Izmir, Turkey.
Department of Medical Genetics, S.B.Ü. Dr. Behçet Uz Children's Education and Research Hospital, Izmir, Turkey.
Int J Dev Neurosci. 2023 Aug;83(5):479-485. doi: 10.1002/jdn.10280. Epub 2023 Jun 19.
Marshall-Smith syndrome (MSS) and Malan syndrome (MS) are both allelic disorders caused by mutations in the NFIX gene. MS is characterized by overgrowth, intellectual disability, distinctive facial features, and accelerated skeletal maturation. On the other hand, clinical features of MSS consist of advanced bone age, dysmorphic features, intellectual disability, and failure to thrive at birth. In this study, we presented the clinical and molecular findings of two different patients with MS and MSS as a rare cause of intellectual disability and reported two novel variants in the NFIX gene. NFIX gene sequencing revealed a novel heterozygous c.1287delC (p.G430Vfs*34) mutation in patient 1 whose clinical diagnosis was compatible with Marshall-Smith syndrome, and in the second patient, physical features consistent with Malan syndrome, was detected a heterozygous one nucleotide duplication, c.303dupC (pCys102LeufsTer17).
马歇尔-史密斯综合征(MSS)和马兰综合征(MS)均是由 NFIX 基因突变引起的等位基因疾病。MS 的特征为过度生长、智力障碍、独特的面部特征和加速的骨骼成熟。另一方面,MSS 的临床特征包括骨龄提前、畸形特征、智力障碍和出生时生长不良。在这项研究中,我们介绍了两名患有 MS 和 MSS 的不同患者的临床和分子发现,这是智力障碍的罕见原因,并报告了 NFIX 基因中的两个新变异。NFIX 基因测序显示,患者 1 存在新的杂合 c.1287delC(p.G430Vfs*34)突变,临床诊断符合马歇尔-史密斯综合征,而在第二位患者中,发现了与马兰综合征一致的物理特征,存在杂合的一个核苷酸重复 c.303dupC(pCys102LeufsTer17)。